American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$510M |
| 2 |
ExxonMobil
XOM
|
+$222M |
| 3 |
Apple
AAPL
|
+$199M |
| 4 |
CRH
CRH
|
+$189M |
| 5 |
Meta Platforms (Facebook)
META
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$387M |
| 2 |
Colgate-Palmolive
CL
|
+$242M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$235M |
| 4 |
Starbucks
SBUX
|
+$183M |
| 5 |
Equinix
EQIX
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.37% |
| 2 | Financials | 12.82% |
| 3 | Healthcare | 11.59% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Mitek Systems
MITK
$853M
| $386K | ﹤0.01% |
34,538
-19,456
| -36% | -$249K |
|
2502
El Pollo Loco
LOCO
$471M
| $385K | ﹤0.01% |
34,044
+5,112
| +18% | +$50.9K |
|
2503
Brinker International
EAT
$10.2B
| $384K | ﹤0.01% |
5,298
| – | – |
|
2504
Allogene Therapeutics
ALLO
$683M
| $381K | ﹤0.01% |
163,539
+39,498
| +32% | +$117K |
|
2505
EPR Properties
EPR
$4.73B
| $381K | ﹤0.01% |
+9,076
| New | +$373K |
|
|
NTST
2506
NETSTREIT Corp
NTST
$2.09B
| $380K | ﹤0.01% |
23,619
+2,624
| +12% | +$45.1K |
|
2507
Cogent Biosciences
COGT
$6.47B
| $379K | ﹤0.01% |
44,997
-7,032
| -14% | -$53.3K |
|
2508
Chegg
CHGG
$89.3M
| $377K | ﹤0.01% |
119,325
+11,992
| +11% | +$59.6K |
|
2509
LifeVantage
LFVN
$81.9M
| $377K | ﹤0.01% |
58,728
| – | – |
|
2510
Ironwood Pharmaceuticals
IRWD
$674M
| $376K | ﹤0.01% |
57,624
-269,509
| -82% | -$1.91M |
|
2511
Procore
PCOR
$9.45B
| $375K | ﹤0.01% |
5,659
-1,319
| -19% | -$91.5K |
|
2512
Absci
ABSI
$1.62B
| $375K | ﹤0.01% |
121,800
+29,723
| +32% | +$138K |
|
2513
Matrix Service
MTRX
$328M
| $375K | ﹤0.01% |
37,714
+4,452
| +13% | +$50.9K |
|
2514
TaskUs
TASK
$667M
| $372K | ﹤0.01% |
27,976
+2,863
| +11% | +$36.9K |
|
2515
UNIFI
UFI
$120M
| $370K | ﹤0.01% |
62,743
-539
| -0.9% | -$3.21K |
|
2516
Park Hotels & Resorts
PK
$3.03B
| $368K | ﹤0.01% |
24,582
| – | – |
|
2517
FVCBankcorp
FVCB
$339M
| $368K | ﹤0.01% |
33,710
-2,321
| -6% | -$25.7K |
|
|
GTM
2518
ZoomInfo Technologies
GTM
$1.25B
| $368K | ﹤0.01% |
28,825
+9,049
| +46% | +$127K |
|
2519
Boston Omaha
BOC
$431M
| $368K | ﹤0.01% |
27,327
+4,599
| +20% | +$68K |
|
|
AGR
2520
DELISTED
Avangrid, Inc.
AGR
| $366K | ﹤0.01% |
10,303
+560
| +6% | +$20.2K |
|
2521
Driven Brands
DRVN
$2.12B
| $366K | ﹤0.01% |
28,748
-11,290
| -28% | -$143K |
|
|
WBA
2522
DELISTED
Walgreens Boots Alliance
WBA
| $366K | ﹤0.01% |
30,234
+157
| +0.5% | +$2.66K |
|
2523
Organogenesis Holdings
ORGO
$226M
| $365K | ﹤0.01% |
130,259
-97,626
| -43% | -$262K |
|
2524
Merit Medical Systems
MMSI
$5.4B
| $362K | ﹤0.01% |
4,216
+118
| +3% | +$9.28K |
|
2525
Enanta Pharmaceuticals
ENTA
$391M
| $362K | ﹤0.01% |
27,892
+7,287
| +35% | +$98.4K |
|
Similar funds
American Century Companies's Q2 2024 Portfolio in Review
As of Q2 2024, American Century Companies held 3,009 positions worth $163B, up 2.7% from $159B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
American Century Companies's Q2 2024 filing shows 89 new, 1,863 increased, 760 reduced and 131 closed positions. Its largest new stake was UL Solutions: 1,631,475 shares worth $68.8M. The largest sale was UnitedHealth, an estimated $387M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2024 buy was UL Solutions: 1,631,475 shares worth $68.8M.
- American Century Companies added most to iShares Russell 1000 Growth ETF in Q2 2024, an estimated $510M increase.
- American Century Companies's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $387M.
- American Century Companies fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $235M.
- American Century Companies's ten largest holdings make up 27% of its $163B portfolio in Q2 2024.
- American Century Companies opened 89 new positions and closed 131 in Q2 2024.
- American Century Companies's portfolio value rose 2.7% quarter-over-quarter to $163B.
Based on American Century Companies's 13F filing for Q2 2024, filed 7 Aug 2024.